Your browser doesn't support javascript.
loading
Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis.
Naumann, Nicole; Lübke, Johannes; Baumann, Sofie; Schwaab, Juliana; Hoffmann, Oliver; Kreil, Sebastian; Dangelo, Vito; Reiter, Lukas; Bugert, Peter; Kristensen, Thomas; Sotlar, Karl; Haselmann, Verena; Schneider, Sven; Metzgeroth, Georgia; Weiss, Christel; Popp, Henning D; Fabarius, Alice; Hofmann, Wolf-Karsten; Cross, Nicholas C P; Reiter, Andreas; Jawhar, Mohamad.
Afiliação
  • Naumann N; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Lübke J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Baumann S; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Schwaab J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Hoffmann O; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Kreil S; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Dangelo V; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Reiter L; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Bugert P; Institute of Transfusion Medicine and Immunology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Kristensen T; Mastocytosis Center, Odense University Hospital, 5000 Odense, Denmark.
  • Sotlar K; Department of Pathology, Odense University Hospital, 5000 Odense, Denmark.
  • Haselmann V; University Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria.
  • Schneider S; Institute for Clinical Chemistry, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Metzgeroth G; Institute for Clinical Chemistry, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Weiss C; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Popp HD; Department of Medical Statistics and Biomathematics, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Fabarius A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Hofmann WK; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Cross NCP; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • Reiter A; School of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
  • Jawhar M; Wessex Regional Genetics Laboratory, Salisbury SP2 8BJ, UK.
Int J Mol Sci ; 22(5)2021 Mar 04.
Article em En | MEDLINE | ID: mdl-33806359
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-kit / Mastocitose Sistêmica / Mutação Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-kit / Mastocitose Sistêmica / Mutação Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article